Adjuvant immunotherapy: Clinical Trials

3 trials of Adjuvant immunotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 not yet recruiting. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Recruiting 2, Not yet recruiting 1

Follow Adjuvant immunotherapy: new trials by email Literature Review of Adjuvant immunotherapy trials Research Report on Adjuvant immunotherapy

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Perioperative Immunotherapy, Adjuvant Immunotherapy or Neoadjuvant Immunotherapy for Resectable Stage II-IIIA NSCLC
Peroperative immunotherapy, Neoadjuvant immunotherapy, Adjuvant immunotherapy - Resectable Stage II-IIIa NSCLC
Phase 3RecruitingFudan University7592026-05-012026-09-10
De-Escalation Surgery After Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
De-escalation surgery, Standard Surgery, radiotherapy - Squamous Cell Carcinoma of the Head and Neck
Phase 3Not yet recruitingShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University3562026-01-012026-01-06
Reduced-target Resection After Induction Chemotherapy in Resectable Recurrent Nasopharyngeal Carcinoma
Reduced-target resection, Full-target resection, Adjuvant immunotherapy - Nasopharyngeal Carcinoma, De-escaltion Therapy
Phase 3RecruitingSun Yat-sen University4242023-05-202023-05-26

Conditions studied

Lung Neoplasms (1)  ·  Nasopharyngeal Carcinoma (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Sponsors

Fudan University (1)  ·  Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (1)  ·  Sun Yat-sen University (1)

Countries

China (3)

Top investigators

Ming-Yuan Chen, MD, PhD (1)